Kova Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: seeing what it charges before you answer any medical questions
Kova scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $299 a month; its compounded tirzepatide, at $399, is 48% above the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $299/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Kova now names its drugs: compounded semaglutide at $299 a month and tirzepatide at $399 on the 1-month plan, after a first month of $249 or $299. Longer commitments bring the monthly rate down to $129 and $199, but quitting early reprices finished months at the standard rate. LifeTech Apps Inc, a Delaware company, runs it on Telegra's provider and pharmacy network, with a companion app for side effects, protein and weight. Medication, delivery and clinician review are in the plan price.
Is Kova legit?
Yes. Kova is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.1/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Kova promo or coupon code?
Kova has no coupon code to enter. New patients are currently quoted $249 for the first month, then $299 a month, and the discount applies on its own. Coupon sites advertising a "Kova promo code" are not a source we can vouch for.
See how Kova compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Kova
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Kova at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $299/mo
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How Kova scores
Six columns, each one computed from something Kova has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
2.2/10$399/month is 48% above the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Kova
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Kova
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Kova involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Kova shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Kova which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $299, tirzepatide $399. That leaves out membership fees, first-month rates and insurance copays.
- Kova serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Kova
- Kova offers email support
Cancelling Kova
Taken from the terms Kova publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Month to month on the single-month option; the longer options lock in their full term
- Refund policy
- Billing periods already begun and shipped medication are non-refundable
- Early-termination fee
- Yes
Medications Kova lists
Kova lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
First month $249, then $299/month. Commitment plans: 3 months $179/mo ($537 upfront), 6 months $149/mo ($894), 12 months $129/mo ($1,548). Clinician review, medication and delivery included.
First month $299, then $399. Commitment plans: 3 months $249/mo ($747 upfront), 6 months $229/mo ($1,374), 12 months $199/mo ($2,388).
Check the price yourself before you pay
Every figure here comes from Kova's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Kova
Against it
- Semaglutide costs $299 a month, 50% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $399 a month, 48% above the $269 median for compounded tirzepatide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Kova charges
The figure Kova leads with is $249, and it is a first-month rate. From month two the price is $299/month, which is the number to plan around. There is nothing wrong with an introductory offer; it just is not the price of staying on the medication.
- Compounded semaglutide: $249 first month, then $299/month
- Compounded tirzepatide: $299 first month, then $399/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Kova's $399 is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much. Before you pay, compare Kova's cancellation terms with other sellers' cancellation and refund policies. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Direct Meds dispenses semaglutide and tirzepatide from $249/month, which makes it the fair comparison to run before you commit here.
What Kova dispenses
Kova prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
Kova tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. We found no FDA warning letters issued to Kova. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Kova will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Kova bills your plan before you start.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
- you need access wherever you live
Our read
Kova is a cheap way to start and an ordinary way to continue. Use the $249 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $299/month before you let it renew twice. MangoRx is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Kova scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $299 a month; its compounded tirzepatide, at $399, is 48% above the $269 median among the sellers we compare.
Before you pay Kova
Starting at $299 a month. Check today's price, then start the intake.
Where Kova is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Kova sets more sellers in the same category beside Kova on price, states and what the price includes.
Frequently Asked Questions
How to check Kova yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
Every seller that ships to your state, side by side: Iowa, Louisiana, Maine, Massachusetts, Montana, Oklahoma, Pennsylvania, Wisconsin and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Kova review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Kova's current pricing
Plans start at $249 a month. Whether you qualify is a clinician's decision, made after your intake.